Literature DB >> 377496

Human growth hormone: complementary DNA cloning and expression in bacteria.

J A Martial, R A Hallewell, J D Baxter, H M Goodman.   

Abstract

The nucleotide sequence of a DNA complementary to human growth hormone messenger RNA was cloned; it contains 29 nucleotides in its 5' untranslated region, the 651 nucleotides coding for the prehormone, and the entire 3' untranslated region (108 nucleotides). The data reported predict the previously unknown sequence of the signal peptide of human growth hormone and, by comparison with the previously determined sequences of rat growth hormone and human chorionic somatomammotropin, strengthens the hypothesis that these genes evolved by gene duplication from a common ancestral sequence. The human growth hormone gene sequences have been linked in phase to a fragment of the trp D gene of Escherichia coli in a plasmid vehicle, and a fusion protein is synthesized at high level (approximately 3 percent of bacterial protein) under the control of the regulatory region of the trp operon. This fusion protein (70 percent of whose amino acids are coded for by the human growth hormone gene) reacts specifically with antibodies to human growth hormone and is stable in E. coli.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 377496     DOI: 10.1126/science.377496

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  65 in total

Review 1.  'Molecular farming' of antibodies in plants.

Authors:  Stefan Schillberg; Rainer Fischer; Neil Emans
Journal:  Naturwissenschaften       Date:  2003-02-18

2.  Opposing actions of intact and N-terminal fragments of the human prolactin/growth hormone family members on angiogenesis: an efficient mechanism for the regulation of angiogenesis.

Authors:  I Struman; F Bentzien; H Lee; V Mainfroid; G D'Angelo; V Goffin; R I Weiner; J A Martial
Journal:  Proc Natl Acad Sci U S A       Date:  1999-02-16       Impact factor: 11.205

3.  Versatile retrovirus vector systems for regulated gene expression in vitro and in vivo.

Authors:  D Lindemann; E Patriquin; S Feng; R C Mulligan
Journal:  Mol Med       Date:  1997-07       Impact factor: 6.354

4.  Analysis of DNA haplotypes suggests a genetic predisposition to trisomy 21 associated with DNA sequences on chromosome 21.

Authors:  S E Antonarakis; S D Kittur; C Metaxotou; P C Watkins; A S Patel
Journal:  Proc Natl Acad Sci U S A       Date:  1985-05       Impact factor: 11.205

5.  Antigen design enhances the immunogenicity of Semliki Forest virus-based therapeutic human papillomavirus vaccines.

Authors:  P P Ip; A Boerma; M Walczak; K Oosterhuis; J B Haanen; T N Schumacher; H W Nijman; T Daemen
Journal:  Gene Ther       Date:  2015-03-26       Impact factor: 5.250

6.  Human growth hormone and prolactin secreting pituitary adenomas analyzed by in situ hybridization.

Authors:  R V Lloyd; M Cano; W F Chandler; A L Barkan; E Horvath; K Kovacs
Journal:  Am J Pathol       Date:  1989-03       Impact factor: 4.307

7.  Silent somatotroph adenomas of the human pituitary. A morphologic study of three cases including immunocytochemistry, electron microscopy, in vitro examination, and in situ hybridization.

Authors:  K Kovacs; R Lloyd; E Horvath; S L Asa; L Stefaneanu; D W Killinger; H S Smyth
Journal:  Am J Pathol       Date:  1989-02       Impact factor: 4.307

8.  Human growth hormone: recent advances and current status.

Authors:  M J Bourgeois
Journal:  Indian J Pediatr       Date:  1986 Mar-Apr       Impact factor: 1.967

9.  Growth hormone (GH) and prolactin (PRL) gene expression and immunoreactivity in GH- and PRL-producing human pituitary adenomas.

Authors:  J Li; L Stefaneanu; K Kovacs; E Horvath; H S Smyth
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1993

10.  Expression of the human growth hormone variant gene in cultured fibroblasts and transgenic mice.

Authors:  R F Selden; T E Wagner; S Blethen; J S Yun; M E Rowe; H M Goodman
Journal:  Proc Natl Acad Sci U S A       Date:  1988-11       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.